Allergy

Reports indicate the patient presented with Ebola-like symptoms at a local emergency room and told staff he had recently traveled to Africa. If so, why wasn't CDC protocol followed, and why was the man sent home?

Patients with the relapsing-remitting form of multiple sclerosis have shown improvement with glatiramer acetate. Although it is unclear exactly how the drug works, recently published research has shed light on the ways in which glatiramer acetate affects B cells.

New research from Northwestern University has found that schools are woefully unprepared to deal with anaphylaxis and other life-threatening emergencies stemming from student allergies.

New research indicates that doctors who treat anaphylaxis with intravenous epinephrine rather than intramuscular or subcutaneous injections are increasing the risk that patients will suffer overdoses or other adverse reactions.

New questions about the risks of flying and the responsibilities of airlines have followed reports of anaphylaxis cases on two international flights in less than a month.

Monitoring patients' own intestinal immune responses, researchers at Yale University have identified some of the bacterial culprits driving inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis.

New research suggests that oral immunotherapy may trigger anaphylaxis in an unusually high percentage of asthmatic teenagers with high-risk food allergies who failed to adhere to their management plan.

A new multi-step skin testing protocol effectively determines the presence of isosulfan blue allergy, according to a study conducted by researchers at the University of Virginia.

Analysis of fatal cases of anaphylaxis in Canada uncovers several trends that point to a need for more effective monitoring and treatment strategies in high-risk patients.

New research about food allergies that can trigger severe reactions such as anaphylaxis has shown that cooking some foods can prevent attacks and help build tolerance.

A California-based company has taken the final step toward bringing a cheaper epinephrine injection kit to the American market.

Dust mites are widely responsible for allergic irritation and breathing difficulties, but researchers from the University of Iowa researchers indicated a vaccine may be within reach.

The US Food and Drug Administration announced the approval of a new drug for the treatment of chronic obstructive pulmonary disease.

The recent death of a Canadian politician who was stung by wasps has drawn renewed attention to the dangers of anaphylaxis and the need for increased allergy testing.

Recent efforts to overhaul standards of care for both food allergies in general and anaphylaxis in particular led expert panels from the European Academy of Allergy and Clinical Immunology to a shocking conclusion.

Researchers from the Ecole Polytechnique Federale de Lausanne report having developed a fast and accurate method for determining exactly which milk proteins produce allergic reactions in specific patients.

Analysis of emergency department cases indicates that anaphylaxis severity increases with age and other health problems, but preparations can reduce the danger to patients.

A taskforce from the European Academy of Allergy and Clinical Immunology has reviewed all the published research and formulated a new set of comprehensive guidelines for diagnosing and treating anaphylaxis.

New research has reached the unexpected conclusion that non-steroidal anti-inflammatory drugs (NSAIDs) may rank among the top causes of drug-induced anaphylaxis.

Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.

Comparatively few patients treated for anaphylaxis in the emergency department are prescribed adrenaline autoinjectors, and many who do receive them either do not know how to properly use the device or fail to carry it with them at all times.

Are most people who show mild sensitivity to bee venom a sting away from developing systemic allergies and suffering anaphylaxis? New research suggests the answer is no, but they are in danger of serious reactions at the sting site.

The reductions in brain volume often seen in patients with chronic relapsing–remitting multiple sclerosis may be reduced by treatment with interferon beta-1a, though treatment may be affected by the patient's immunologic status.

Children delivered by cesarean section and those given antibiotics early in infancy may be more prone to developing allergic inflammation of the esophagus.

Research from the Mayo Clinic suggests that an order set designed to standardize the treatment of anaphylaxis in emergency departments may lead to improved guideline adherence and better treatment outcomes.

New research may help doctors predict when patients who have suffered one attack of anaphylaxis will undergo a second attack without any additional exposure to the original trigger.

Study results presented at the 2014 American Thoracic Society International Conference show that treatment with rosuvastatin reduces markers of inflammation in patients with COPD after 12 weeks, but is not associated with improvements in measures of lung function.

Study results presented at the 2014 American Thoracic Society International Conference show that treatment with simvastatin did not decrease exacerbation rates or time to first exacerbation in patients with COPD.

Researchers reported no treatment effects after 12 weeks in a population of patients with persistent moderate to severe allergic asthma.

New research shows that food allergies may have increased more far more quickly among black children than among American children as a whole, leading to increased risk of anaphylaxis.